These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 22196068)
21. [Fatal outcome after overdosage with antidepressants]. Gude MF; Jensen LT; Bjerre-Kristensen L Ugeskr Laeger; 2014 Feb; 176(7A):V07130443. PubMed ID: 25347564 [TBL] [Abstract][Full Text] [Related]
22. [Serotonin syndrome in the course of drug-poisoning--case presentation]. Majewska M; Szponar J; Pyra E; Kostek H; Kujawa A Przegl Lek; 2011; 68(8):523-6. PubMed ID: 22010456 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the "serotonin syndrome". Dingemanse J; Wallnöfer A; Gieschke R; Guentert T; Amrein R Clin Pharmacol Ther; 1998 Apr; 63(4):403-13. PubMed ID: 9585794 [TBL] [Abstract][Full Text] [Related]
24. Fluoxetine-induced cardiotoxicity with response to bicarbonate therapy. Graudins A; Vossler C; Wang R Am J Emerg Med; 1997 Sep; 15(5):501-3. PubMed ID: 9270390 [TBL] [Abstract][Full Text] [Related]
25. Serotonin toxicity caused by moclobemide too soon after paroxetine-selegiline. Wu ML; Deng JF J Chin Med Assoc; 2009 Aug; 72(8):446-9. PubMed ID: 19687003 [TBL] [Abstract][Full Text] [Related]
28. Fatal moclobemide overdose or death caused by serotonin syndrome? Hernandez AF; Montero MN; Pla A; Villanueva E J Forensic Sci; 1995 Jan; 40(1):128-30. PubMed ID: 7876795 [TBL] [Abstract][Full Text] [Related]
29. Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finnish postmortem data. Koski A; Vuori E; Ojanperä I Int J Legal Med; 2005 Nov; 119(6):344-8. PubMed ID: 15739105 [TBL] [Abstract][Full Text] [Related]
31. Fluoxetine overdose in a teenager resulting in serotonin syndrome, seizure and delayed onset rhabdomyolysis. Lee-Kelland R; Zehra S; Mappa P BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30301727 [TBL] [Abstract][Full Text] [Related]
32. The management of depression. Part 2. The place of the new antidepressants. Mitchell PB; Mitchell MS Aust Fam Physician; 1994 Sep; 23(9):1771-3, 1776-81. PubMed ID: 7980178 [TBL] [Abstract][Full Text] [Related]
33. Fluoxetine versus other types of pharmacotherapy for depression. Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD004185. PubMed ID: 24353997 [TBL] [Abstract][Full Text] [Related]
34. Moclobemide versus fluoxetine in the treatment of inpatients with major depression. Gattaz WF; Vogel P; Kick H; Kohnen R J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):35S-40S. PubMed ID: 7593728 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview. Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236 [TBL] [Abstract][Full Text] [Related]
37. An uncommon fatality due to moclobemide and paroxetine. Singer PP; Jones GR J Anal Toxicol; 1997 Oct; 21(6):518-20. PubMed ID: 9323537 [TBL] [Abstract][Full Text] [Related]
38. [Poisoning with antidepressants]. Bodmer M Ther Umsch; 2009 May; 66(5):335-41. PubMed ID: 19401983 [TBL] [Abstract][Full Text] [Related]
39. [Poisoning with a reversible and selective monoaminooxidase inhibitor]. Pall M; Bested KM; Eriksen ND Ugeskr Laeger; 1997 Aug; 159(32):4859-60. PubMed ID: 9273760 [TBL] [Abstract][Full Text] [Related]
40. Moclobemide. An update of its pharmacological properties and therapeutic use. Fulton B; Benfield P Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]